Sai Life Sciences informs about allotment of equity shares under ESOP

27 Jun 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III to the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (‘Listing Regulations’), Sai Life Sciences has informed that the Board of Directors of the Company has approved and allotted 40,403 fully paid-up equity shares of Re.1/ each upon exercise of options granted under MESOP 2018, vide circular resolution dated 26th June, 2025. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed as Annexure-A. Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024 are enclosed as Annexure-B.

The above information is a part of company’s filings submitted to BSE.

Sai Life Sciences Share Price

896.45 -3.70 (-0.41%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×